Candida Auris Strikes Three Oregon Hospitals

First case was detected at Salem Hospital Dec. 11 in patient who had recent international healthcare exposures, and confirmed Dec. 17

By HFT Editorial Staff


The Oregon Health Authority (OHA) recently announced that it is investigating an outbreak of the state’s first cases of Candida auris, a serious fungal infection that is often resistant to multiple antifungal medicines.The Healthcare-Associated Infections Program at the OHA Public Health Division, working with a regional public health laboratory in Seattle and Salem Hospital, have identified Candida auris in three Salem Health patients. The first case was detected at Salem Hospital Dec. 11 in a patient who had recent international healthcare exposures, and confirmed Dec. 17. Candida auris has only recently appeared in the United States.

Two of the cases did not have international healthcare exposures but had epidemiologic links to first case, indicating healthcare-associated spread of Candida auris to the second and third patients, which were identified Dec. 23 and Dec. 27, respectively.

“Candida aurisis an emerging pathogen of concern because it can cause serious infections, particularly in those with serious medical problems, and can be resistant to the antifungal drugs we have to treat it,” said Rebecca Pierce, Healthcare-Associated Infections Program manager. “Fortunately, the organism we’re dealing with in this outbreak appears to respond to existing treatments. Nonetheless, it’s critical that we prevent the spread of the infection.”

Jasmin Chaudhary, medical director of infection prevention at Salem Health, said the health system is taking action on a number of fronts to prevent the spread of Candida auris at Salem Hospital.

“With the COVID-19 pandemic, we have seen a rise in multi-drug resistant organisms around the world and nationwide, and Salem is not immune,” Chaudhary said. “Salem Health is working with OHA and the CDC to execute a rigorous plan, implementing aggressive eradication measures that have been shown in other hospitals to be successful in eliminating Candida auris. These include proactive steps that will assist in preemptively identifying new cases to prevent spread.”

Among the measures in effect: working with the patients’ care teams to ensure frequent and effective disinfection of the healthcare environment; using transmission-based precautions for those infected or colonized with Candida auris; adhering to hand hygiene protocols; and conducting effective interfacility-transfer communication about a patient’s Candida auris status when being transferred to another health care facility.

Candida auris is a type of yeast that can cause severe illness, particularly those suffering from serious medical conditions in hospitals and nursing homes. The risk of Candida auris infection to otherwise healthy people, including healthcare personnel, is extremely low.The fungus can cause serious infections, including bloodstream infections and wound infections.



January 4, 2022


Topic Area: Infection Control


Recent Posts

Rethinking How Healthcare Facilities Fund Construction Projects

Rising costs and competing priorities are driving healthcare organizations to explore new financing arrangements and construction strategies.


Winners Named for the 15th Annual Healthcare Design Awards

All winners will be honored and the Best of Competition and Transformation and Innovation Award recipients will be announced during a celebration on November 12.


Intermountain Health Breaks Ground on New Children's Hospital in Nevada

Plans call for a 33-acre campus, an approximately 828,600-square-foot hospital with an initial 180-bed inpatient tower that can expand to 228 beds.


Ambulatory Care Facilities Reshape FM Strategies

Facilities management playbooks were written for acute care facilities, but ambulatory sites require a different approach.


Intermountain Foundation Receives $150M Gift for Children's Hospital in Nevada

Intermountain Health Felicia and Ben Horowitz Children’s Hospital is expected to open in 2030 at the UNLV Harry Reid Research and Technology Park in southwest Las Vegas.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.